Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications.
暂无分享,去创建一个
Gregory Y H Lip | G. Lip | E. Shantsila | Eduard Shantsila | M. Dzeshka | V. Snezhitskiy | Mikhail S Dzeshka | Viktor Snezhitskiy
[1] V. Petrov,et al. Transforming growth factor-beta 1-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts. , 2002, Methods and findings in experimental and clinical pharmacology.
[2] K. Schlüter,et al. TGFβ receptor activation enhances cardiac apoptosis via SMAD activation and concomitant NO release , 2011, Journal of cellular physiology.
[3] J. D’Armiento,et al. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. , 2000, The Journal of clinical investigation.
[4] S. Miyagawa,et al. Impact of microRNA Expression in Human Atrial Tissue in Patients with Atrial Fibrillation Undergoing Cardiac Surgery , 2013, PloS one.
[5] Arantxa González,et al. Increased Collagen Type I Synthesis in Patients With Heart Failure of Hypertensive Origin: Relation to Myocardial Fibrosis , 2004, Circulation.
[6] Michael F Swartz,et al. Dominant Frequency Increase Rate Predicts Transition from Paroxysmal to Long-Term Persistent Atrial Fibrillation , 2014, Circulation.
[7] Xiaobin Luo,et al. Role for MicroRNA-21 in Atrial Profibrillatory Fibrotic Remodeling Associated With Experimental Postinfarction Heart Failure , 2012, Circulation. Arrhythmia and electrophysiology.
[8] Andrew J Taylor,et al. Magnetic resonance post-contrast T1 mapping in the human atrium: validation and impact on clinical outcome after catheter ablation for atrial fibrillation. , 2014, Heart rhythm.
[9] Yuan Zhang,et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. , 2013, Heart rhythm.
[10] B. Khandheria,et al. Role of imaging in assessment of atrial fibrosis in patients with atrial fibrillation: state-of-the-art review. , 2014, European heart journal cardiovascular Imaging.
[11] A. Goette,et al. Atrial fibrillation and rapid acute pacing regulate adipocyte/adipositas-related gene expression in the atria. , 2015, International journal of cardiology.
[12] Yun Zhang,et al. Myocardial ultrasonic integrated backscatter analysis in patients with chronic atrial fibrillation , 2010, The International Journal of Cardiovascular Imaging.
[13] Chien-Huang Lin,et al. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes. , 2011, Circulation journal : official journal of the Japanese Circulation Society.
[14] Michael F Swartz,et al. Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation. , 2012, Journal of the American College of Cardiology.
[15] A. Camm,et al. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[16] R. McKelvie,et al. Relation of Peripheral Collagen Markers to Death and Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction: Results of the I-PRESERVE Collagen Substudy , 2011, Circulation. Heart failure.
[17] Leif Hove-Madsen,et al. PITX2 Insufficiency Leads to Atrial Electrical and Structural Remodeling Linked to Arrhythmogenesis , 2011, Circulation. Cardiovascular genetics.
[18] Gary R. Grotendorst. Connective tissue growth factor: a mediator of TGF-β action on fibroblasts , 1997 .
[19] M. Chung,et al. Association of Left Atrial Endothelin-1 With Atrial Rhythm, Size, and Fibrosis in Patients With Structural Heart Disease , 2010, Circulation. Arrhythmia and electrophysiology.
[20] Jun-zhu Chen,et al. Possible involvement of fibrocytes in atrial fibrosis in patients with chronic atrial fibrillation. , 2014, Circulation journal : official journal of the Japanese Circulation Society.
[21] L. Ling,et al. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. , 2012, Journal of the American College of Cardiology.
[22] Gary R. Grotendorst. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. , 1997, Cytokine & growth factor reviews.
[23] S. Hazen,et al. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation , 2010, Nature Medicine.
[24] Jeroen J. Bax,et al. Non-invasive imaging in atrial fibrillation: focus on prognosis and catheter ablation , 2014, Heart.
[25] A. Capucci,et al. Sleep-Disordered Breathing and Atrial Fibrillation: Review of the Evidence , 2015, Cardiology in review.
[26] J. Molkentin,et al. Periostin as a Heterofunctional Regulator of Cardiac Development and Disease , 2008, Current genomics.
[27] Vijay Devabhaktuni,et al. Long-Term Frequency Gradients During Persistent Atrial Fibrillation in Sheep Are Associated With Stable Sources in the Left Atrium , 2012, Circulation. Arrhythmia and electrophysiology.
[28] Jifeng Zhang,et al. Integrated analysis of microRNA and mRNA expression profiles in the left atrium of patients with nonvalvular paroxysmal atrial fibrillation: Role of miR-146b-5p in atrial fibrosis. , 2015, Heart rhythm.
[29] Gernot Plank,et al. Mechanistic inquiry into the role of tissue remodeling in fibrotic lesions in human atrial fibrillation. , 2013, Biophysical journal.
[30] S. Nattel,et al. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. , 2014, Journal of the American College of Cardiology.
[31] Reza Nezafat,et al. Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement: a pilot study. , 2009, JACC. Cardiovascular imaging.
[32] Shenming Wang,et al. Atrial Fibrillation Induces Myocardial Fibrosis Through Angiotensin II Type 1 Receptor–Specific Arkadia-Mediated Downregulation of Smad7 , 2011, Circulation research.
[33] Hiroshi Ashikaga,et al. Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study. , 2015, Circulation. Cardiovascular imaging.
[34] Michael Jerosch-Herold,et al. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. , 2013, JACC. Cardiovascular imaging.
[35] A. J. Valente,et al. Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK. , 2013, Journal of molecular and cellular cardiology.
[36] K. Gatter,et al. Atrial fibrillation is associated with cardiac hypoxia. , 2010, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[37] Hongli Li,et al. Expression of miR-133 and miR-30 in chronic atrial fibrillation in canines. , 2012, Molecular medicine reports.
[38] I. V. Van Gelder,et al. University of Groningen Atrial Remodeling Is Directly Related to End-Diastolic Left Ventricular Pressure in a Mouse Model of Ventricular Pressure Overload , 2013 .
[39] S. Nattel,et al. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. , 2008, Journal of the American College of Cardiology.
[40] K. Griendling,et al. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. , 2007, American journal of physiology. Cell physiology.
[41] Chunxiang Zhang,et al. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. , 2009, Journal of molecular and cellular cardiology.
[42] J. Svendsen,et al. Atrial fibrillation: the role of common and rare genetic variants , 2022 .
[43] Jean-Claude Tardif,et al. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. , 2014, Journal of the American College of Cardiology.
[44] R. Duisters,et al. MIRNA-133 AND MIRNA-30 REGULATE CONNECTIVE TISSUE GROWTH FACTOR: IMPLICATIONS FOR A ROLE OF MIRNAS IN MYOCARDIAL MATRIX REMODELING , 2013 .
[45] Yijiang Chen,et al. OPG/RANK/RANKL Axis in Stabilization of Spontaneously Restored Sinus Rhythm in Permanent Atrial Fibrillation Patients after Mitral Valve Surgery , 2012, Cardiology.
[46] T. Chao,et al. Transforming growth factor-β1 level and outcome after catheter ablation for nonparoxysmal atrial fibrillation. , 2013, Heart rhythm.
[47] Nassir Marrouche,et al. Association of Atrial Fibrosis Quantified Using LGE‐MRI with Atrial Appendage Thrombus and Spontaneous Contrast on Transesophageal Echocardiography in Patients with Atrial Fibrillation , 2013, Journal of cardiovascular electrophysiology.
[48] Joshua J. E. Blauer,et al. Detection and Quantification of Left Atrial Structural Remodeling With Delayed-Enhancement Magnetic Resonance Imaging in Patients With Atrial Fibrillation , 2009, Circulation.
[49] Q. Xie,et al. Meta-analysis Identifies Serum C-Reactive Protein as an Indicator of Atrial Fibrillation Risk After Coronary Artery Bypass Graft , 2016, American journal of therapeutics.
[50] J. Cleland,et al. Association of galectin‐3 and fibrosis markers with long‐term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE‐HF (Cardiac Resynchronization in Heart Failure) trial , 2012, European journal of heart failure.
[51] W. Rottbauer,et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts , 2008, Nature.
[52] Jin Wei,et al. Ageing related periostin expression increase from cardiac fibroblasts promotes cardiomyocytes senescent. , 2014, Biochemical and biophysical research communications.
[53] S Nattel,et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. , 1999, Circulation.
[54] G. Hansson,et al. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. , 1998, Circulation research.
[55] D. Corradi. Atrial fibrillation from the pathologist's perspective. , 2014, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[56] R. Blankstein,et al. Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation. , 2014, JACC. Cardiovascular imaging.
[57] J. Nerbonne,et al. MicroRNA-133a Protects Against Myocardial Fibrosis and Modulates Electrical Repolarization Without Affecting Hypertrophy in Pressure-Overloaded Adult Hearts , 2010, Circulation Research.
[58] Prashanthan Sanders,et al. Electrical Remodeling of the Atria in Congestive Heart Failure: Electrophysiological and Electroanatomic Mapping in Humans , 2003, Circulation.
[59] Y. Okumura,et al. Transthoracic echocardiographic backscatter-based assessment of left atrial remodeling involving left atrial and ventricular fibrosis in patients with atrial fibrillation. , 2014, International journal of cardiology.
[60] E. Kholmovski,et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. , 2011, Journal of the American College of Cardiology.
[61] S. Nattel,et al. Differential Behaviors of Atrial Versus Ventricular Fibroblasts: A Potential Role for Platelet-Derived Growth Factor in Atrial-Ventricular Remodeling Differences , 2008, Circulation.
[62] M. Mayr,et al. Targeting myocardial remodelling to develop novel therapies for heart failure , 2014, European Journal of Heart Failure.
[63] Nazem Akoum,et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. , 2014, JAMA.
[64] Marlena Maziarz,et al. Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS). , 2014, American heart journal.
[65] Stanley Nattel,et al. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. , 2014, Circulation research.
[66] A. McLellan,et al. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation. , 2013, Heart rhythm.
[67] Douglas L. Jones,et al. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. , 1995, Circulation.
[68] J. Brugada,et al. Atrial fibrosis in a chronic murine model of obstructive sleep apnea: mechanisms and prevention by mesenchymal stem cells , 2014, Respiratory Research.
[69] M. Rienstra,et al. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation. , 2014, American heart journal.
[70] C. Loewe,et al. Time course of markers of tissue repair after ablation of atrial fibrillation and their relation to left atrial structural changes and clinical ablation outcome. , 2011, International journal of cardiology.
[71] D. Levy,et al. Galectin 3 and incident atrial fibrillation in the community. , 2014, American heart journal.
[72] E. Olson,et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. , 2008, Genes & development.
[73] D. Rueckert,et al. Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: A 2-center study , 2013, Heart rhythm.
[74] Bharath Ambale-Venkatesh,et al. Cardiac MRI: a central prognostic tool in myocardial fibrosis , 2015, Nature Reviews Cardiology.
[75] J. Mariani,et al. Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure , 2013, European journal of heart failure.
[76] M. de Antonio,et al. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3. , 2014, Journal of the American College of Cardiology.
[77] S. Nattel,et al. MicroRNA29: A Mechanistic Contributor and Potential Biomarker in Atrial Fibrillation , 2013, Circulation.
[78] MartaRuiz-Ortega,et al. Angiotensin II Activates the Smad Pathway in Vascular Smooth Muscle Cells by a Transforming Growth Factor-β–Independent Mechanism , 2005 .
[79] Yenn-Jiang Lin,et al. Inflammation and the pathogenesis of atrial fibrillation , 2015, Nature Reviews Cardiology.
[80] Sander Verheule,et al. Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1 , 2004, Circulation research.
[81] A. Malhotra,et al. Effect of Sleep Apnea and Continuous Positive Airway Pressure on Cardiac Structure and Recurrence of Atrial Fibrillation , 2013, Journal of the American Heart Association.
[82] H. Duffy,et al. Fibroblasts and Myofibroblasts: What Are We Talking About? , 2011, Journal of cardiovascular pharmacology.
[83] S. Grajek,et al. Impact of atrial remodeling on heart rhythm after radiofrequency ablation and mitral valve operations. , 2012, The Annals of thoracic surgery.
[84] P. Vardas,et al. Angiotensin II Type 1 Receptor Inhibition is Associated with Reduced Tachyarrhythmia-Induced Ventricular Interstitial Fibrosis in a Goat Atrial Fibrillation Model , 2007, Cardiovascular Drugs and Therapy.
[85] J. Garot,et al. Correlation between AF Substrate Ablation Difficulty and Left Atrial Fibrosis Quantified by Delayed‐Enhancement Cardiac Magnetic Resonance , 2011, Pacing and clinical electrophysiology : PACE.
[86] Jeffrey E. Thatcher,et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis , 2008, Proceedings of the National Academy of Sciences.
[87] A. Leask. Potential Therapeutic Targets for Cardiac Fibrosis: TGF&bgr;, Angiotensin, Endothelin, CCN2, and PDGF, Partners in Fibroblast Activation , 2010, Circulation research.
[88] T. Doetschman,et al. Origin of Cardiac Fibroblasts and the Role of Periostin , 2009, Circulation research.
[89] P. Nilsson,et al. Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study , 2015, Cardiovascular Diabetology.
[90] Yong Li,et al. Increased Expression of Connective Tissue Growth Factor and Transforming Growth Factor-Beta-1 in Atrial Myocardium of Patients with Chronic Atrial Fibrillation , 2013, Cardiology.
[91] M. Pisano,et al. Intracellular dynamics of Smad‐mediated TGFβ signaling , 2003 .
[92] Jeroen J. Bax,et al. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation , 2011, Heart.
[93] Markus Grube,et al. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. , 2010, Journal of the American College of Cardiology.
[94] S. Conway,et al. The Dynamic Role of Cardiac Fibroblasts in Development and Disease , 2012, Journal of Cardiovascular Translational Research.
[95] R. Mahajan,et al. The implications of obesity for cardiac arrhythmia mechanisms and management. , 2015, The Canadian journal of cardiology.
[96] A. Feldman,et al. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. , 2000, Cardiovascular research.
[97] E. Kholmovski,et al. Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE‐MRI Guided Approach , 2011, Journal of cardiovascular electrophysiology.
[98] I. V. Van Gelder,et al. New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[99] M. Volpe,et al. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. , 2009, Clinical science.
[100] Seung‐Jung Park,et al. Transforming growth factor β1-mediated atrial fibrotic activity and the recovery of atrial mechanical contraction after surgical maze procedure. , 2013, International journal of cardiology.
[101] F. Spinale,et al. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. , 1998, Circulation research.
[102] P. Schauerte,et al. Decreased Plasminogen Activator Inhibitor and Tissue Metalloproteinase Inhibitor Expression May Promote Increased Metalloproteinase Activity with Increasing Duration of Human Atrial Fibrillation , 2007, Journal of cardiovascular electrophysiology.
[103] Christopher McGann,et al. Atrial Fibrillation Ablation Outcome Is Predicted by Left Atrial Remodeling on MRI , 2014, Circulation. Arrhythmia and electrophysiology.
[104] V. Shusterman,et al. Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-{alpha}. , 2005, American journal of physiology. Heart and circulatory physiology.
[105] R. Kalluri,et al. The origin of fibroblasts and mechanism of cardiac fibrosis , 2010, Journal of cellular physiology.
[106] A. McLellan,et al. Diffuse Ventricular Fibrosis Measured by T1 Mapping on Cardiac MRI Predicts Success of Catheter Ablation for Atrial Fibrillation , 2014, Circulation. Arrhythmia and electrophysiology.
[107] H. Hermeking,et al. MicroRNA-34a regulates cardiac ageing and function , 2013, Nature.
[108] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[109] Richard T. Lee,et al. Intramyocardial Fibroblast Myocyte Communication , 2010, Circulation research.
[110] G. Hindricks,et al. Galectin-3 in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation , 2015, PloS one.
[111] E. Kholmovski,et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. , 2010, Heart rhythm.
[112] A. Oto,et al. A Prospective DE‐MRI Study Evaluating the Role of TGF‐β1 in Left Atrial Fibrosis and Implications for Outcomes of Cryoballoon‐Based Catheter Ablation: New Insights into Primary Fibrotic Atriocardiomyopathy , 2015, Journal of cardiovascular electrophysiology.
[113] Y. Okumura,et al. Impact of Biomarkers of Inflammation and Extracellular Matrix Turnover on the Outcome of Atrial Fibrillation Ablation: Importance of Matrix Metalloproteinase‐2 as a Predictor of Atrial Fibrillation Recurrence , 2011, Journal of cardiovascular electrophysiology.
[114] Yijiang Chen,et al. Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation. , 2013, International journal of cardiology.
[115] R. Blankstein,et al. The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation . , 2013, Journal of the American College of Cardiology.
[116] Alexandru B. Chicos,et al. Atrial and ventricular fibrosis induced by atrial fibrillation: evidence to support early rhythm control. , 2008, Heart rhythm.
[117] R. Sheppard,et al. Fibrosis in heart disease: understanding the role of transforming growth factor‐β1 in cardiomyopathy, valvular disease and arrhythmia , 2006, Immunology.
[118] B. Kalionis,et al. The Role of Oxidative Stress and Inflammation in Cardiovascular Aging , 2014, BioMed research international.
[119] J. Olgin,et al. Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1. , 2013, Cardiovascular research.
[120] Jérôme Kalifa,et al. Risk Factors and Genetics of Atrial Fibrillation. , 2016, Heart failure clinics.
[121] R. Kalluri,et al. Origins of cardiac fibroblasts. , 2010, Circulation research.
[122] L. Tokgozoglu,et al. Effects of persistent atrial fibrillation on serum galectin-3 levels. , 2015, The American journal of cardiology.
[123] Christopher McGann,et al. Echocardiographic left atrial reverse remodeling after catheter ablation of atrial fibrillation is predicted by preablation delayed enhancement of left atrium by magnetic resonance imaging. , 2010, American heart journal.
[124] Shufeng Zhou,et al. Activated nuclear factor-κB and increased tumor necrosis factor-α in atrial tissue of atrial fibrillation , 2009, Scandinavian cardiovascular journal : SCJ.
[125] P. Vardas,et al. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover. , 2008, Journal of the American College of Cardiology.
[126] D. McManus,et al. Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention. , 2011, Critical pathways in cardiology.
[127] G. Nuovo,et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. , 2009, Cardiovascular research.
[128] Zhouqin Jiang,et al. Association Between C‐Reactive Protein and Atrial Fibrillation Recurrence After Catheter Ablation: A Meta‐analysis , 2013, Clinical cardiology.
[129] G. Lip,et al. Left ventricular fibrosis in atrial fibrillation. , 2013, The American journal of cardiology.
[130] T. Marwick,et al. Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade , 2013, Heart.
[131] G. Lip,et al. Role of microRNAs in cardiac remodelling: new insights and future perspectives. , 2013, International journal of cardiology.
[132] U. Laufs,et al. Role of miR-21 in the pathogenesis of atrial fibrosis , 2012, Basic Research in Cardiology.
[133] Hui Chen,et al. Relationship Between Integrated Backscatter and Atrial Fibrosis in Patients with and Without Atrial Fibrillation Who Are Undergoing Coronary Bypass Surgery , 2009, Clinical cardiology.
[134] M. Yacoub,et al. Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators. , 2015, Cardiovascular research.
[135] T. Munzel,et al. Atrial fibrosis and atrial fibrillation: the role of the TGF-β1 signaling pathway. , 2010, International journal of cardiology.
[136] D. Kaye,et al. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. , 2015, European heart journal cardiovascular Imaging.
[137] A. Ballestrero,et al. Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase. , 2006, Cardiovascular research.
[138] W. Daniel,et al. Atrial distribution of connexin 40 and 43 in patients with intermittent, persistent, and postoperative atrial fibrillation. , 2006, Heart, lung & circulation.
[139] R. Fenici,et al. Cardiac biopsy in patients with "primary" atrial fibrillation. Histologic evidence of occult myocardial diseases. , 1991, Chest.
[140] J. Jalife. Mechanisms of persistent atrial fibrillation , 2014, Current opinion in cardiology.
[141] A. Camm,et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, European heart journal.
[142] Paul A. Overbeek,et al. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice , 2000, Nature Medicine.
[143] Nolwenn Le Meur,et al. Contrasting Gene Expression Profiles in Two Canine Models of Atrial Fibrillation , 2007, Circulation research.
[144] D. Haines,et al. Electrical, Morphological, and Ultrastructural Remodeling and Reverse Remodeling in a Canine Model of Chronic Atrial Fibrillation , 2000, Circulation.
[145] Stephanie L. K. Bowers,et al. Cardiac Fibroblast: The Renaissance Cell , 2009, Circulation research.
[146] J. Risteli,et al. Atrial extracellular matrix remodelling in patients with atrial fibrillation , 2007, Journal of cellular and molecular medicine.
[147] K. Nishigaki,et al. Left atrial pathological degeneration assessed by integrated backscatter transesophageal echocardiography as a predictor of progression to persistent atrial fibrillation: Results from a prospective study of three-years follow-up , 2012, Cardiovascular Ultrasound.
[148] Ichiro Manabe,et al. Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling , 2011, International journal of inflammation.